Company: IPST
Filing Date: 2025-12-12
Form Type: S-1/A
Source: 0001213900-25-121277
Chunk: 240

Company: Heritage Distilling Holding Company, Inc.
Filing Date: 2025-12-12
Form: S-1/A
Chunk 240
---
 in which we have an ownership stake of no less than 10%; or upon our receipt of a third -partyvaluation or outside investment valuing our company as a whole or any subsidiary at $200 million or more. (2)The value reflected is based upon the fair grant value of $80.00 per share.

140

DIRECTOR COMPENSATION General The following discussion describes the significant elements of the expected compensation program for members of the board of directors and its committees. The compensation of our directors is designed to attract and retain committed and qualified directors and to align their compensation with the long -terminterests of our shareholders. Directors who are also executive officers (each, an “Excluded Director”) are not entitled to receive any compensation for his or her service as a director, committee member or Chair of our board of directors or of any committee of our board of directors. Director Compensation We have accrued, but never paid, a cash retainer to directors for their service on the Board. Independent directors who served in 2024 agreed to defer cash compensation until after our November 2024 initial public offering. Independent directors earned $10,000 per year in cash compensation for services rendered in 2023 and 2024, calculated pro rata if a full year was not served. The following table sets forth the aggregate non -employeedirector compensation earned for services for the year ended December 31, 2024 (excluding compensation to our executive officers set forth in the summary compensation table above). Directors Wensel, Baumann, Trevan, Alstead, and Varga agreed to defer receipt of their fees until 2025.

| Name                        |     | Fees Earned or  
 Paid in Cash(1) |        |     | Stock  
 Awards |         |     | All Other    
 Compensation |   |     | Total 
 ($)   |         |
|:----------------------------|:----|:----------------|-------:|:----|:-------|--------:|:----|:-------------|:--|:----|:------|--------:|
| Jeffrey Wensel, M.D., Ph.D. |     | $               | 10,000 |     | $      |  96,000 |     | $            | — |     | $     | 106,000 |
| Laura Baumann(2)            |     |                 |  1,667 |     |        |       — |     |              | — |     |       |   1,667 |
|